Repligen
RGEN
#1864
Rank
ยฃ8.00 B
Marketcap
ยฃ125.18
Share price
-3.81%
Change (1 day)
5.62%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): -ยฃ0.15

According to Repligen 's latest financial reports the company's current EPS (TTM) is -ยฃ0.15. In 2025 the company made an earnings per share (EPS) of ยฃ0.66 an increase over its 2024 EPS that were of -ยฃ0.39.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.15-123.05%
2025ยฃ0.66-270.59%
2024-ยฃ0.39-168%
2023ยฃ0.57-77.68%
2022ยฃ2.5743.59%
2021ยฃ1.79105.26%
2020ยฃ0.87153.33%
2019ยฃ0.3418.42%
2018ยฃ0.29-47.95%
2017ยฃ0.56108.57%
2016ยฃ0.2720.69%
2015ยฃ0.2216%
2014ยฃ0.19-48.98%
2013ยฃ0.376.52%
2012ยฃ0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54-455.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ14.51-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ6.67-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.45-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ0.29 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-ยฃ1.16 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.33-3,585.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.89-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06877-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ0.78-610.00%๐Ÿ‡บ๐Ÿ‡ธ USA